Analyst Joel Beatty works at BAIRD and is covering the the Healthcare sector with 552 price targets and ratings documented since 2012 spanning on 50 stocks. Previously, Joel Beatty worked at CITI.
Joel Beatty's average stock forecast success ratio is 46.78% with an average time for price targets to be met of 177.52 days.
Most recent stock forecast was given on TCON, TRACON Pharmaceuticals, Inc at 11-May-2023.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS INC).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS INC) at 5/11/2022. The price target of $18 was fulfilled within 6 days with a profit of $4.96 (38.04%) receiving and performance score of 63.39.
Average potential price target upside
Currently, out of the existing stock ratings of Joel Beatty - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
275
$82.7 (43.01%)
250
6 days ago
3/5 (60%)
$27.87 (14.78%)
119
Hold
210
$17.7 (9.20%)
205
2 months 2 days ago
13/14 (92.86%)
$36.4 (23.25%)
145
Buy
415
$222.7 (115.81%)
415
3 months 3 days ago
1/8 (12.5%)
$174.99 (108.91%)
664
Buy
240
$47.7 (24.80%)
240
3 months 13 days ago
7/8 (87.5%)
$18.94 (11.53%)
233
Buy
291
$98.7 (51.33%)
310
3 months 13 days ago
1/3 (33.33%)
$70.62 (43.94%)
337
